RNU7-128P

Across TCGA pan-cancer cohorts, RNU7-128P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU7-128P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU7-128P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-128P expression acts as an unfavorable survival marker, although some lineages such as GBM and READ show a favorable association.

KIRC, ACC, and CESC are the cancer types where RNU7-128P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.441	0.668	<.001	62	view →
ACC	OS	Tertile	All	0.546	0.889	.004	57	view →
CESC	OS	Quartile	IV	0.191	0.748	<.001	42	view →
THCA	DFS	Tertile	All	0.802	0.927	.009	30	view →
SARC	DFS	Tertile	All	0.434	0.634	.001	30	view →
GBM	OS	Tertile	All	0.610	0.387	.016	27	view →
BRCA	OS	Tertile	All	0.889	0.930	.010	24	view →
LGG	OS	Tertile	All	0.776	0.901	.001	21	view →
PAAD	DFS	Tertile	All	0.279	0.489	.038	18	view →
READ	OS	Tertile	II,III,IV	1.000	0.566	.029	18	view →
ESCA	DFS	Quartile	All	0.370	0.550	.021	10	view →
KICH	DFS	Tertile	III,IV	0.043	0.897	.045	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU7-128P–KIRC (OS)

Open the KIRC breakdown →